Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1922]
News [4599]
Articles [467]
Editorials [10]
Conferences [114]
elearning [42]

LORELEI trial of letrozole and taselisib for ER positive breast cancer

Dr Cristina Saura - Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain
LORELEI trial of letrozole and taselisib for ER positive breast cancer ( Dr Cristina Saura - Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain )
11 Sep 2017

Fertility-preserving procedures in BRCA mutation-positive breast cancer

Dr Matteo Lambertini - Institut Jules Bordet, Brussels, Belgium
Fertility-preserving procedures in BRCA mutation-positive breast cancer ( Dr Matteo Lambertini - Institut Jules Bordet, Brussels, Belgium )
11 Sep 2017

ABP 980, a biosimilar antibody for trastuzumab

Dr Richard Markus - Amgen, Conejo Valley, USA
ABP 980, a biosimilar antibody for trastuzumab ( Dr Richard Markus - Amgen, Conejo Valley, USA )
10 Sep 2017

Abemaciclib for advanced breast cancer

Dr Angelo Di Leo - Hospital of Prato, Tuscany, Italy
Abemaciclib for advanced breast cancer ( Dr Angelo Di Leo - Hospital of Prato, Tuscany, Italy )
10 Sep 2017

Comment: MONARCH 3 trial: Abemaciclib for advanced breast cancer

Dr Evandro de Azambuja - Jules Bordet Institute, Brussels, Belgium
Comment: MONARCH 3 trial: Abemaciclib for advanced breast cancer ( Dr Evandro de Azambuja - Jules Bordet Institute, Brussels, Belgium )
10 Sep 2017

MONARCH 3: Abemaciclib as initial therapy for patients with HR /HER2- advanced breast cancer

Dr Angelo Di Leo - Hospital of Prato, Tuscany, Italy
MONARCH 3: Abemaciclib as initial therapy for patients with HR /HER2- advanced breast cancer ( Dr Angelo Di Leo - Hospital of Prato, Tuscany, Italy )
10 Sep 2017

Small node-negative breast cancers may retain aggressive characteristics

Dr Konstantinos Tryfonidis - European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium
Small node-negative breast cancers may retain aggressive characteristics ( Dr Konstantinos Tryfonidis - European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium )
9 Sep 2017

Adaptive TONIC trial of nivolumab combinations for breast cancer

Dr Marleen Kok - Netherlands Cancer Institute, Amsterdam, Netherlands
Adaptive TONIC trial of nivolumab combinations for breast cancer ( Dr Marleen Kok - Netherlands Cancer Institute, Amsterdam, Netherlands )
9 Sep 2017

STORM trial to identify genetic variability in metastatic breast cancer

Dr David Cox - Cancer Research Center of Lyon, Lyon, France
STORM trial to identify genetic variability in metastatic breast cancer ( Dr David Cox - Cancer Research Center of Lyon, Lyon, France )
9 Sep 2017

The UNICANCER-NeoPAL study of letrozole and palbociclib in luminal cancer

Dr Paul Cottu - Institut Curie, Paris, France
The UNICANCER-NeoPAL study of letrozole and palbociclib in luminal cancer ( Dr Paul Cottu - Institut Curie, Paris, France )
9 Sep 2017

Problems with survivorship care in Europe

Prof Francesco De Lorenzo - University of Naples Federico II, Naples, Italy
Problems with survivorship care in Europe ( Prof Francesco De Lorenzo - University of Naples Federico II, Naples, Italy )
9 Sep 2017

Underprovision and inequality of specialised cancer care

Dr Emmanouil Saloustros - General Hospital of Heraklion 'Venizelio', Crete, Greece
Underprovision and inequality of specialised cancer care ( Dr Emmanouil Saloustros - General Hospital of Heraklion 'Venizelio', Crete, Greece )
9 Sep 2017

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation